BioCentury | Feb 12, 2021
Product Development
Tau vaccine moving toward late-stage trials for Alzheimer’s
AC Immune believes it has hit on a breakthrough in vaccine technology with its Alzheimer’s candidate ACI-35. The rest of the world will have to wait to evaluate the claim, as the company and partner...